FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop

Qinkai Zhang1, Xunzhu Zhou1, Maoping Wan1

  • 1Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China.

Cell Death & Disease
|March 16, 2021
PubMed

Insights

MicroRNA-150 (miR-150) acts as a tumor suppressor in ovarian cancer (OC) by inhibiting the IGF1R/IRS1 pathway. Its downregulation correlates with poor outcomes, while restoration suppresses OC growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Ovarian cancer (OC) is a leading cause of gynecological cancer deaths.
  • Deregulation of microRNAs (miRNAs) and the insulin-like growth factor 1 receptor/insulin receptor substrate 1 (IGF1R/IRS1) pathway are implicated in OC progression.

Purpose of the Study:

  • To investigate the role and regulatory mechanisms of miR-150 in ovarian cancer.
  • To elucidate the molecular functions of miR-150 in OC development and progression.

Main Methods:

  • Analysis of miR-150 expression in OC tissues and correlation with patient outcomes.
  • In vitro and in vivo experiments to assess the effects of ectopic miR-150 expression on OC cells.
  • Luciferase reporter assays and Western blotting to identify direct targets and signaling pathways involved.
  • Chromatin immunoprecipitation and promoter analysis to determine upstream regulators.

Main Results:

  • miR-150 expression was downregulated in OC tissues and associated with poor patient prognosis.
  • Restoring miR-150 expression inhibited OC cell proliferation, migration, and invasion.
  • IGF1R and IRS1 were identified as direct targets of miR-150, with the miR-150-IGF1R/IRS1 axis suppressing the PI3K/AKT/mTOR pathway.
  • Forkhead box protein 3 (FoxP3) positively regulated miR-150 expression, forming a feedback loop with the PI3K/AKT/mTOR pathway.

Conclusions:

  • miR-150 functions as a tumor suppressor miRNA in ovarian cancer.
  • A novel feedback loop involving FoxP3, miR-150, IGF1R/IRS1, and the PI3K/AKT/mTOR pathway regulates OC pathogenesis.
  • These findings offer potential therapeutic targets for ovarian cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K